Literature DB >> 7350806

Tuberculosis in patients with end-stage renal disease.

O T Andrew, P Y Schoenfeld, P C Hopewell, M H Humphreys.   

Abstract

Ten patients with proved disease caused by Myocobacterium tuberculosis were identified over a 10 year period in a population of 172 adult patients undergoing long-term dialysis. The incidence of tuberculosis was 12 times greater than that prevailing in the general community during the period of the study and could not be accounted for solely by demographic factors. Diagnosis was obscured because the symptoms were nonspecific and attributable to uremia, intermediate strength (5 TU) tuberculin tests were often negative, the roentgenographic appearance of pulmonary disease was often atypical, and there was more frequent extrapulmonary involvement. Impaired cellular immunity due to advanced renal failure may predispose to the increased incidence of tuberculosis and the greater frequency of extrapulmonary disease observed. Treatment was safe and effective in these patients using 300 mg of isoniazid and 8 to 10 mg/kg of ethambutol daily. Eight patients survived longer than one year following the diagnosis of tuberculosis, and all were clinically cured. No deaths were directly attributed to tuberculosis. A high index of suspicion and aggressive evaluation may be necessary to diminish the significant mortality described previously in association with disseminated disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350806     DOI: 10.1016/0002-9343(80)90166-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  28 in total

1.  Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis.

Authors:  W A Nockher; J E Scherberich
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  High incidence of tuberculosis in renal patients.

Authors:  M E García-Leoni; C Martín-Scapa; P Rodeño; F Valderrábano; S Moreno; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

3.  Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.

Authors:  J-Y Wang; P-R Hsueh; I-S Jan; L-N Lee; Y-S Liaw; P-C Yang; K-T Luh
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 4.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 5.  Morbidity and mortality of long-term haemodialysis: a review.

Authors:  R Gabriel
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

Review 6.  Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature.

Authors:  Rapur Ram; Guditi Swarnalatha; Tekin Akpolat; Kalogotla Venkata Dakshinamurty
Journal:  Int Urol Nephrol       Date:  2012-11-10       Impact factor: 2.370

7.  Tuberculosis and renal transplantation--observations from an endemic area of tuberculosis.

Authors:  K K Malhotra; S C Dash; I K Dhawan; U N Bhuyan; A Gupta
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

8.  Breast mycobacterial infection in a haemodialysis patient.

Authors:  D Modai; J Weissgarten; R Reiff; B Siegal; D Gabizon
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

9.  [A case of pregnancy with fetal malformation and an hepatic hydatid cyst].

Authors:  B Nalbanski; P Popivanova; V Lachev; S Ivanov; K Tsekova
Journal:  Akush Ginekol (Sofiia)       Date:  2001

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.